IVZ | ||
---|---|---|
OUTLOOK RATING 1..100 | 14 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 19 Undervalued | |
PROFIT vs RISK RATING 1..100 | 44 | |
SMR RATING 1..100 | 87 | |
PRICE GROWTH RATING 1..100 | 4 | |
P/E GROWTH RATING 1..100 | 17 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CZA | IVZ | |
---|---|---|
RSI ODDS (%) | N/A | 2 days ago71% |
Stochastic ODDS (%) | 2 days ago77% | 2 days ago67% |
Momentum ODDS (%) | 2 days ago77% | 2 days ago70% |
MACD ODDS (%) | 2 days ago81% | 6 days ago48% |
TrendWeek ODDS (%) | 2 days ago82% | 2 days ago72% |
TrendMonth ODDS (%) | 2 days ago81% | 2 days ago69% |
Advances ODDS (%) | 5 days ago81% | 2 days ago71% |
Declines ODDS (%) | 7 days ago74% | 8 days ago66% |
BollingerBands ODDS (%) | 2 days ago76% | N/A |
Aroon ODDS (%) | 2 days ago79% | 2 days ago72% |
A.I.dvisor tells us that CZA and IVZ have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CZA and IVZ's prices will move in lockstep.
A.I.dvisor indicates that over the last year, IVZ has been closely correlated with CG. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if IVZ jumps, then CG could also see price increases.